eBook Download
BOOK EXCERPT:
Product Details :
Genre | : Science |
Author | : Caiyun Fu |
Publisher | : Frontiers Media SA |
Release | : 2022-02-18 |
File | : 339 Pages |
ISBN-13 | : 9782889744282 |
Download PDF Ebooks Easily, FREE and Latest
WELCOME TO THE LIBRARY!!!
What are you looking for Book "Clinical Therapeutic Development Against Cancers Resistant To Targeted Therapies" ? Click "Read Now PDF" / "Download", Get it for FREE, Register 100% Easily. You can read all your books for as long as a month for FREE and will get the latest Books Notifications. SIGN UP NOW!
Genre | : Science |
Author | : Caiyun Fu |
Publisher | : Frontiers Media SA |
Release | : 2022-02-18 |
File | : 339 Pages |
ISBN-13 | : 9782889744282 |
This volume will bring together a review of research being carried out by international experts in this field, detailing treatment and research approaches in several forms of malignant brain tumors. These include glioblastoma (GBM), a highly aggressive and fatal form of astrocytoma which accounts for 80% of newly diagnosed brain tumor patients per year, and meningioma, of which 10% are malignant and extremely resistant to targeted therapies. The volume will also include a discussion of methods to overcome blood-brain barrier exclusion for more efficient targeted drug delivery in all forms of brain cancer treatment. The volume will include information on the repurposing of drugs in an attempt to circumvent drug resistance, use of small molecule inhibitors in GBM treatment, mechanisms of secondary brain metastasis, drug resistance, and state-of-the-art imaging of targeted therapies.
Genre | : Medical |
Author | : Amanda Tivnan |
Publisher | : Springer |
Release | : 2016-11-26 |
File | : 267 Pages |
ISBN-13 | : 9783319465050 |
Targeted Therapy in Translational Cancer Research for the Translational Oncology series provides a comprehensive overview of recent developments in our understanding of tumor biology, elucidates the roles of targets and pathways involved in carcinogenesis, and describes current state-of-the-art anticancer therapy, as well as the most promising areas of translational research and targeted therapy. Introduces cutting-edge ‘bench to bedside and back’ breakthroughs which have transformed the diagnosis, prognosis, and treatment of cancer Covers basic principles of targeted therapy, including immunotherapy and the roles of cancer stem cells, the microenvironment, angiogenesis, epigenetics, microRNAs, and functional imaging in precision medicine Summarises major advances in therapeutic management of hematologic malignancies and solid tumors using conventional therapy, targeted therapy, immunotherapy, or novel treatment modalities
Genre | : Medical |
Author | : Apostolia-Maria Tsimberidou |
Publisher | : John Wiley & Sons |
Release | : 2015-10-14 |
File | : 396 Pages |
ISBN-13 | : 9781118468661 |
We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.
Genre | : Medical |
Author | : Jenifer R. Prosperi |
Publisher | : Springer |
Release | : 2017-12-04 |
File | : 193 Pages |
ISBN-13 | : 9783319701424 |
In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they will result in a better selection of patients with sensitive disease and the establishment of suitable combinations of drugs that target different molecules and could overcome the established resistance.
Genre | : Medical |
Author | : Andrés J. M. Ferreri |
Publisher | : Springer |
Release | : 2018-04-04 |
File | : 143 Pages |
ISBN-13 | : 9783319751849 |
Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. However, the development of resistance to these combinatorial approaches has led to the reassessment of currently available therapeutic options to overcome resistance to targeted therapy. This book aims to provide an update on the advancements in the therapeutic arms race between cancer, clinicians and scientists alike to overcome resistance to targeted therapies. Subject experts provide a comprehensive overview of the challenges and solutions to resistance to several conventional targeted therapies in addition to providing a discussion on broad topics including targeting components of the tumor microenvironment, emerging therapeutic options, and novel areas to be explored concerning nanotechnology and the epigenome.
Genre | : Medical |
Author | : Myron R. Szewczuk |
Publisher | : Springer |
Release | : 2019-07-15 |
File | : 328 Pages |
ISBN-13 | : 9783030214777 |
Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called "target" therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy. This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
Genre | : Medical |
Author | : Ana C. Xavier |
Publisher | : Springer Nature |
Release | : 2019-09-13 |
File | : 220 Pages |
ISBN-13 | : 9783030244248 |
This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient’s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.
Genre | : Medical |
Author | : Ravi Salgia |
Publisher | : Springer |
Release | : 2019-06-26 |
File | : 244 Pages |
ISBN-13 | : 9783030178321 |
Genre | : Science |
Author | : Daniela Spano |
Publisher | : Frontiers Media SA |
Release | : 2022-03-03 |
File | : 206 Pages |
ISBN-13 | : 9782889745708 |
Genre | : Medical |
Author | : Wafik S. El-Deiry |
Publisher | : Frontiers Media SA |
Release | : 2023-09-26 |
File | : 320 Pages |
ISBN-13 | : 9782832534342 |